CYMABAY THERAPEUTICS INC's ticker is CBAY and the CUSIP is 23257D103. A total of 123 filers reported holding CYMABAY THERAPEUTICS INC in Q3 2020. The put-call ratio across all filers is 0.29 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $252 | +25.4% | 23,000 | 0.0% | 0.03% | +21.4% |
| Q1 2023 | $201 | +219.0% | 23,000 | +130.0% | 0.03% | +211.1% |
| Q4 2022 | $63 | -99.8% | 10,000 | 0.0% | 0.01% | +80.0% |
| Q3 2022 | $35,000 | +16.7% | 10,000 | 0.0% | 0.01% | +25.0% |
| Q2 2022 | $30,000 | -45.5% | 10,000 | -33.3% | 0.00% | -50.0% |
| Q3 2021 | $55,000 | -15.4% | 15,000 | 0.0% | 0.01% | -20.0% |
| Q2 2021 | $65,000 | -4.4% | 15,000 | 0.0% | 0.01% | -9.1% |
| Q1 2021 | $68,000 | -26.1% | 15,000 | -6.2% | 0.01% | -31.2% |
| Q4 2020 | $92,000 | -20.7% | 16,000 | 0.0% | 0.02% | -27.3% |
| Q3 2020 | $116,000 | +107.1% | 16,000 | 0.0% | 0.02% | +100.0% |
| Q2 2020 | $56,000 | +133.3% | 16,000 | 0.0% | 0.01% | +83.3% |
| Q1 2020 | $24,000 | -22.6% | 16,000 | 0.0% | 0.01% | 0.0% |
| Q4 2019 | $31,000 | -62.2% | 16,000 | 0.0% | 0.01% | -64.7% |
| Q3 2019 | $82,000 | -28.7% | 16,000 | 0.0% | 0.02% | -34.6% |
| Q2 2019 | $115,000 | -45.8% | 16,000 | 0.0% | 0.03% | -46.9% |
| Q1 2019 | $212,000 | +3.4% | 16,000 | -38.5% | 0.05% | -9.3% |
| Q4 2018 | $205,000 | -28.8% | 26,000 | 0.0% | 0.05% | -18.2% |
| Q3 2018 | $288,000 | -17.5% | 26,000 | 0.0% | 0.07% | -21.4% |
| Q2 2018 | $349,000 | +27.8% | 26,000 | +23.8% | 0.08% | +33.3% |
| Q1 2018 | $273,000 | +41.5% | 21,000 | 0.0% | 0.06% | +43.2% |
| Q4 2017 | $193,000 | +14.2% | 21,000 | 0.0% | 0.04% | +10.0% |
| Q3 2017 | $169,000 | +47.0% | 21,000 | +5.0% | 0.04% | +37.9% |
| Q2 2017 | $115,000 | +167.4% | 20,000 | +100.0% | 0.03% | +163.6% |
| Q1 2017 | $43,000 | – | 10,000 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management IV, LLC | 1,787,094 | $26,645,572 | 14.80% |
| Lynx1 Capital Management LP | 994,161 | $14,822,941 | 9.80% |
| Octagon Capital Advisors LP | 3,073,750 | $45,829,613 | 7.04% |
| Saturn V Capital Management LP | 1,124,459 | $16,765,684 | 7.02% |
| Altium Capital Management LP | 800,000 | $11,928,000 | 6.22% |
| Affinity Asset Advisors, LLC | 1,129,376 | $16,838,996 | 4.74% |
| ACUTA CAPITAL PARTNERS, LLC | 418,000 | $6,232,380 | 4.18% |
| Cormorant Asset Management, LP | 3,850,000 | $57,403,500 | 3.35% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 590,000 | $8,796,900 | 2.67% |
| MPM BioImpact LLC | 610,770 | $9,106,581 | 2.43% |